Select Page

South Delhi Pharma, New Delhi, India

BEOVU (brolucizumab-dbll) injection, for intravitreal injection.

(8 customer reviews)

Under Named Patient Supply, SDP serve you through the quality pharmaceutical products as per your needs. Established in the year 1996. SDP have earned global reputation in the market and has widest range of Anti Cancer medicines in India. To get the best price/cost of medicines in India, Call 9891296838 or Email query@southdelhipharma.com to discuss.

BEOVU is a prescription medicine. BEOVU used for Neovascular (Wet) Age-Related Macular Degeneration (AMD).
INDICATIONS AND USAGE
BEOVU is a human vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of Neovascular (Wet) Age-Related Macular Degeneration (AMD)
DOSAGE FORMS & STRENGTHS
Intravitreal injection: 6 mg/0.05 mL solution in a single-dose vial
Manufactured By: Novartis Pharmaceuticals Corporation
Prescribing Information URL: Click Here

South Delhi Pharma can facilitate the supply of “BEOVU ® (brolucizumab-dbll) injection” to all locations in India and other part of countries after fulfilling the legal requirement (if applicable). All Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from South Delhi Pharma.

Get In Touch

Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.

The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:
info@southdelhipharma.com

Brolucizumab, sold under the trade name Beovu, is a humanized single-chain antibody fragment for the treatment of neovascular (wet) age-related macular degeneration (AMD). Brolucizumab was designed to attach to and block a substance called vascular endothelial growth factor A (VEGF-A). VEGF-A is a protein that makes blood vessels grow and leak fluid and blood, damaging the macula. By blocking VEGF-A, brolucizumab reduces the growth of the blood vessels and controls the leakage and swelling.

8 reviews for BEOVU (brolucizumab-dbll) injection, for intravitreal injection.

There are no reviews yet.

Be the first to review “BEOVU (brolucizumab-dbll) injection, for intravitreal injection.”

Your email address will not be published. Required fields are marked *